A remarkable clinical response in advanced gastric cancer treated with trastuzumab plus capecitabine combination chemotherapy: A report of two cases

摘要

Key Clinical Message When trastuzumab?+?capecitabine and cisplatin chemotherapy could not be conducted continuously because of severe adverse reactions to cisplatin, trastuzumab?+?capecitabine could be an alternative systemic chemotherapy options for metastatic or recurrent gastric cancer patients.